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The use of allografts has been used in clinical practice for many years for the treatment of
orthopaedic or cardiovascular disorders. There is always a risk of disease transmission with the
use of allograft although it appears to be diminishing through the rigorous screening of donors,
and improved harvesting and banking techniques. Whatever method is used, the graft cannot be
guaranteed sterile and some centers use methods such as irradiation or ethylene oxide treatment
for secondary decontamination of the grafts. These forms of sterilization can influence the bio-
logical and/or biomechanical characteristics of the allografts. Another method of reducing the
risk of infection is to minimize contamination during the harvesting of the allograft in operating
theaters. This contamination, through contact of the graft with the operating room air or with
non-sterile surfaces, is also greater from cadaveric donors at the end of multiorgan harvest, than
from living donors. Some experimental protocols recommend the rinsing of contaminated grafts
with antiseptic or antibiotic solutions. Since antibiotic disinfection procedures were developed to
treat heart valve allografts for tissue banking in 1969, several different combinations of antibi-
otics have been used to treat fresh and/or cryopreserved heart valves. However, antibiotic toxicity
can be a problem in situations where cellular viability of the tissues is considered important. In
the last part, development of antibiotics with modified composition to improve cellular viability
and its practical applications to cryopreserved vascular tissues were described on the basis of our
previous studies.
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INTRODUCTION
Over the last few decades, the uses of
various allogenic and xenogenic grafts
have proved to be reliable methods for the
reconstruction of orthopaedic and cardio-
vascular defects. These grafts received
from multiorgan donors should be micro-
biologically sterile and might be either
transplanted immediately or cryopreserved
for future use. With the use of trans-
planted graft, however, there is the
potential risk of transmission of infective
particles. In spite of optimal surgical tech-
nique and routine prophylactic treat-
ments, from 3 to 5% of vascular grafts
obtained from multiorgan donors have
been reported to be contaminated3 4 ). The
incidence of infection associated with the
use of allograft bone has also been report-
ed to be between 5 and 13%2 9 , 3 6 , 3 8 , 6 1 , 6 2 )a n d
there have been reports of the implanta-
tion of contaminated allografts2 9 , 3 6 , 6 0 - 6 2 ). As
the allograft bone commonly used in
orthopaedic surgery is different form
other surgical grafts, cellular viability of
the tissues is not so much considered
mportant(Table 1). However, microbial
infection can be fetal to the viability
/or durability of the post-operative
allograft tissues and lead even to death,
related to severe inflammatory reaction.
To prevent these microbiological contami-
nations, various sterilization methods
have been tried and employed(Table 2).
Up to now, the known treatments might
be d vided into physical methods and
chem reatments. High temperature
steam(autoclaving), gas, gamma or ultra-
violet ray, plasma, and ultrasound can be
used in physical sterilization. Though all
chemical compounds with cytotoxicity
might belong to antibiotics(Table 3), the
antibiotic toxicity can kill tissue cells and
modify graft properties, which result in
graft failure in a few years post-trans-
p l a n t a t i o n4 1 ). In our previous studies4 5 ),
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Table 1.Consideration of cellular viability of tissue graft
cellular viability necessary cellular viability selective
most grafts except grafts related grafts related to orthopaedic surgery
to orthopaedic surgery (except cartilage)
cardiovascular tissue or organ cancellous bone
skin cortical bone
liver hip joint
lung
kidney
pancreas
esophagus
nerve
cornea
...
cartilage, marrow etc.
modified antibiotic composition was devel-
oped to improve cellular viability, to max-
imize sterilizing power and to trigger syn-
ergistic effect, and then applied to cryop-
reserv d vascular tissues.
The general purpose of a tissue bank is
to provide safe and effective allografts for
p a t i en t s1 9 ). Sterile tissue recovery in an
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Table 2.Possible applications to allografts according to sterilization methods
sterilization advantages disadvantages applicationsviability consideration
high temperatureelimination of spore- possible contamination orthopaedic
steam forming bacteria by outer air on fast surgery ×
(121℃, 15 min) within 30 min freezing
penetration into skin irritation
ethylene oxide bacterial cell burns and haemolysis orthopaedic ×
gas (55℃) wall, inhibition of exposure to air surgery
cell growth
electro-magnetic ineffectiveness to
ultraviolet ray
breakage of disinfection of packed or tissue
(254 nm)
microbial cells, irregular specimen withoutdisinfection, but ×
sterilization of penetration into less effective
surface microbes opaque materials
gamma
sterilization of HIV or expensive equipments,no safety proof
irradiation
hepatitis C in human unsuitable for common for vascular ×
cortical bone grafts hospital facilities grafts
chemical
all chemical lethality to tissue graft,
all transplanted ○
treatments
compounds with selection of optimal
grafts
cytotoxicity conditions & spectrum
Table 3.Comparison of chemical sterilization methods
chemical agent properties application examples
all antibiotics inhibition of bacterial cell wall
penicillin, tetracycline, and protein synthesis, reported in many literatures
clindamycin, detrimental to mammalian cells (skin16), vein13,51,53), aorta13,33)
ampotericin B etc. resistance to specific chemical etc.)
peracetic acid used in disinfection of open femoral head from 
-ethanol wounds with chlorhexidine hip replacement55),
no histological injury/low toxicity cornea49)
10% povidone bactericidal, fungicidal, virucidal defatted human
-iodine solution and sporicidal effects spongiosa48)
ethylene oxide
penetration into inner side of cancellous bone31,68),
gas
tissue grafts cortical bone32,50,63,66),
elimination bacteria and virus allodermis10)
operating theatre is required for the col-
lection of allografts transplanted without
undergoing secondary sterilization4 0 ).
Cultures from all collected tissues must be
taken, and contaminated allografts dis-
c a r d e d1 9 , 4 0 ). In contrast to living donors,
multiorgan and tissue donors allow recov-
ery of long bones(femurs, tibiae, fibulae,
humeri, radii, ulnae), as well as bone-
tendon-bone complexes such as patella-
patellar-tendon-tibial tubercle grafts,
Achilles tendons with or without bone
blocks, tibial tendons, a  tissues
obtained for special purposes5 4 , 6 2 ). With
increasing demand for allograft bone,
infection of implanted allograft bones is
of increasing concern. However, a univer-
sal consensus on how a bone bank should
be operated has not been reached, and
the experience with graft-associated infec-
tion has not been made widely
a v a i l a b l e3 5 ). Therefore, the goals of this
review are to analyze the relationship
between previous organ and tissue pro-
curements with allograft contamination
and to introduce the efficiency of antibi-
otic sterilization and its practical applica-
tions on the basis of our previous studies.
EO gas sterilization
Allografts have been used in orthopedic
surgery f r many years. Autoclaving is
known to be unsuitable for the steriliza-
t on of bone allografts, because it may
denature structural and bioactive pro-
teins, including collagen and bone mor-
phogenetic proteins. Another method of
sterilization of medical supplies, with eth-
ylene oxide(EO) gas, is widely used in
hospitals and in the medical products
industry; although freeze-dried bone is
not used much for allografts in Japan3 0 ),
EO gas st rilization is now frequently
used in the manufacturing process of this
bone. Zhang et al.6 8 )have reported that
bone induction was little affected clinical-
ly by EO gas sterilization at 40℃. Chip
bone allografts defatted with chloroform
and methanol, freeze-dried, and sterilized
with EO gas have been used in various
procedur s of orthopedic surgery since
1 9 9 41 4 , 1 5 , 3 1 ). It was evident that repeated
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Table 4.Conventional combination of antibiotics
antibioticsa) concentration (μg/ml) 
cefoxitin 240
lincomycin 120
vancomycin 100
polymixin B 50
a) used at Toronto Tissue Bank42-44,53) 
Table 5.Modified combination of antibiotics
antibioticsb) concentration (μg/ml) 
liposomal cefoxitin 625
clindamycin 8
vancomycin 250
polymixin B 250
b) used at Yonsei Cardiovascular Tissue Bank45) 
1. Tissue harvest
2. Antibiotic treatment
3. Cryopreservation
4. Thawing
Fig. 1. Cellular viability changes according to cryop-
reservation process.
pre-operative aeration and more than 2
w e e k s’preservation were recommended
before use for reducing the residual EO
concentration and that intra-operative
rinsing with 500 ml of physiological
saline for 10 min reduced the EO residual
l e v e l3 1 ).
Exposure to EO gas is accepted as an
effective sterilization method for bone
transplants, because EO completely pene-
trates into bone and destroys bacteria and
viruses. The sterilization effect of EO gas
is based on the acylation of amino acids.
Because of the potential carcinogenicity of
EO and its products, the reduction of the
EO residual concentration in allografts is
an urgent problem. EO gas is very soluble
in both water and fat. Defatting and
freeze-drying before EO exposure result in
lower residual concentrations than freeze-
drying after EO exposure. However, expo-
sure to EO residuals has been reported to
cause adverse changes in the human
b o d y3 , 1 8 , 2 0 ).
Cortical bone transplantation is often
performed to fill cortical bone defects fol-
lowing bone fractures or bone tumours2 2 ).
It is not necessary that these cortical
grafts contain viable cells, since they are
mainly used for mechanical support and
as a scaffold for new bone formation.
Therefore, dead cortical bone can be used
as graft3 2 ). Several preservation methods
are used, such as freezing lyophilization
or drying at room temperature.
Contamination of the preserved grafts due
to infectious diseases or as a result of
manipulation is a risk that can be over-
come by sterilizing the graft. The most
commonly used sterilization procedures in
man and animals are high-dose irradia-
tion or EO-sterilization2 1 ). However, steril-
ization and preservation can change the
roperties of the grafts. High-dose irradia-
tion can decrease the biomechanical prop-
e r t i e s5 1 , 5 8 ), the antigenicity and/or the
osteoinductive capacity of the grafts8 ), as
has been described for human trans-
plants. The current EO-sterilization proce-
dures at temperatures of 43.3~64℃a n d
pressures of 7.584 bar decrease the bio-
m hanical properties of dog grafts5 0 , 6 6 ).
According to Aspenberg et al.3 ), EO
d stro s the dose-dependent bone-induc-
tion properties, as is seen for human
transplants. There are no data on the
effect of EO-sterilization on the antigenici-
ty of the bone grafts, either in man or in
animal . Optimally sterilized and pre-
served cortical bone allografts should
r tain their biomechanical and osteoin-
ductive properties and have a reduced
antigenicity. Tshamala et al.6 4 ) d e s c r i b e d
changes in the EO-sterilization procedure
that resulted in preservation of the biome-
chanical properties of dog bone allografts.
It was also demonstrated that the anti-
genicity of dog cortical bone allografts
was ver weak and the EO-sterilization on
dog grafts had no effect on osteoinduc-
tion, but decreased bone resorption6 3 ).
Gamma irradiation
There are presently various techniques
fo  preparing allografts. The most fre-
qu nt y used is cryopreservation in deep
freezers(-40 to -80℃) or liquid nitrogen(-
1 96℃). Cryopreservation has been report-
ed to duce immunogenicity as the
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d o n o r’s cells are destroyed but it has no
effect on bacterial and viral contamina-
t i o n2 4 , 5 2 ). A drastic selection of donors, the
use of a surgical theater with aseptic con-
ditions during harvesting and a serologi-
cal survey are necessary6 ). An additional
3 week antibiotic therapy is also recom-
mended by the American Association of
Orthopedic Surgery and Traumatology2 3 ).
Lyophilization is another method that
implies complete dehydration of bone
samples under vacuum. It provides mate-
rials that can be stored at room tempera-
ture. However, the method works poorly
on large allografts, suffers from prohibi-
tive cost and does not exhibit sterilizing
p r o p e r t i e s5 9 ).
Gamma(or beta) irradiation is presently
a widely accepted procedure and a 25,000
gray dosage is usually recommended.
Irradiation is active on bacteria but its
effects on virus are questionable.
Irradiation was also reported to alter bone
mechanical properties3 7 ). On  should note
that bone pieces that will be used for fill-
ing purposes(e.g., femoral heads) are gen-
erally cleaned of articular cartilage by
grinding before sterilization. However, the
organic components present in the mar-
row cavities are not removed. These are
mainly composed of fatty cells that can
account for a very important fraction of
the total weight for an adult femoral
head: 60~70%. Adipocytes are specialized
cells responsible for lipid synthesis and
storage. When exposed to oxidizing condi-
tions, lipids are known to be altered by
p e r o x i d a t i o n .
It has been shown that extensive defat-
ting was a prerequisite for preparing
xenogenic bone and that incompletely
processed materials induced an inflamma-
tory reaction associated with Langhans-
like gia t cells1 2 ). Gamma irradiation is a
pow ful oxidizing process and its effect
on medullary lipids has never been inves-
tigated. Defatted slices that had been
sterilized by gamma radiations or UV did
not induce cell death, and defatting pro-
cedures should be added when preparing
bone allografts in human bone banks3 9 ).
Chemical treatments
The use of allograft bone in orthopaedic
surgery is ow commonplace. With the
use of transplanted bone, however, there
is potential risk of transmission of infec-
tive particles. The contamination of allo-
graft material is not an uncommon event,
and the incidences reported in the litera-
ture range from 1 to 37%5 , 1 1 , 2 9 , 3 6 , 5 9 , 6 2 ). The
high figure was reported from cadaveric
bone, and there is a lower incidence of
contamination of bone from live donors.
Some exp rimental protocols5 4 , 6 5 )r e   m-
mend the rinsing of contaminated grafts
with antiseptic or antibiotic solutions, but
few studies have analyzed the clinical
benefit of these allograft decontamina-
t i o ns1 7 ). Several methods have described in
literature that offer the possibility of per-
op rative decontamination of autografts
that have been accidentally polluted by
falling on the floor. In the most of these
cases, there are experimental studies of
bac iological efficiency of antibiotic or
antiseptic solutions on bone-tendon grafts
during ligament replacements7 , 2 7 , 4 7 , 5 7 ). For
some years, 10% povidone-iodine solution
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has been used to decontaminate wounds.
It was revealed that a 10% povidone-
iodine solution could decontaminate inoc-
ulated bone grafts, but a sufficient time
of exposure according to the level of cont-
amination must be allowed5 5 ).
In Germany about 25,000 allogenic bone
graft transplantations are performed
annually. Human bone tissue serves as
source material for the production of
these transplants. Accordingly, special
requirements have to be made on the bio-
logical safety of the tissues. Apart from a
validated clinical effectiveness of the
transplants, the quality assurance mea-
sures must focus on the validation of the
sterilization process. In accordance with
the guidelines for managing a bone tissue
bank issued by the Federal Medical
Society, sterilization is particularly indi-
cated if a second testing of the bone tis-
sue donor after an appropriate time can-
not be performed, because the tissue was
obtained from a cadaveric source. In addi-
tion, these validations are required stan-
dards in Germany, where all transplants
manufactured in national tissue banks
are regarded as medicinal products.
So far, no normative specifications exist
regarding validation of the disinfection or
sterilization of bone tissue intended to be
used for transplantation. At present, sev-
eral procedures are used for inactivating
bacteria and fungi, including their spores,
as well as viruses in the context of the
production of bone tissue transplants.
Gamma irradiation, thermal treatment as
well as peracetic acid-ethanol(PES) treat-
ment under negative pressure conditions,
are applied. Pruss et al.4 8 ) d e m o n s t r a t e d
that the PES procedure proved to be a
reliable method for the sterilization of
human bone transplants derived from
spo giosa. However, ethylene oxide as
w l as be a-propiolactone and formalde-
hyde treatment are no longer considered
as suitable methods for sterilization in
Germany, ue to their carcinogenic and
mutagenic effect. Additionally, the latter
clearly reduces the osteoinductive effect.
Therefore, for as long as the last 20
years, ethanol and peracetic acid have
been incre singly used for tissue steriliza-
tion. However, the diffusion of these sub-
stances into the tissue is limited.
Penetra ion-inhibiting fat barriers must
be removed by treating the spongiosa with
a chloroform-methanol mixture or by an
quivalent validated procedure.
Antibiotic treatments
The se of allograft tissues, saphenous
veins, and heart valves for cardiovascular
reconstruction has increased considerably
duri g the last decade. Despite the use of
appropriate systemic antibiotic prophylax-
i , graft infection occurs after 1~6% of
all vascular reconstructions4 6 ). To prevent
this microbial contamination, sterilization
of he graft y using antibiotics has been
mployed for further clinical use9 ).
Sterilization with antibiotics affects the
molecula  tructure of the graft, and cel-
lular viability is related to its subsequent
d u r a b i l i t y5 1 ). Traditional chemical methods
of sterilization can kill all heart valve
cells and modify valve material properties.
S me nvestigators reported that antibiotic
treatments caused morphological
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c h a n g e s2 6 ), inhibited invasion of tissues by
f i b r o b l a s t s2 5 ), and affected viability of
heart valve grafts1 ). Hu et al.2 8 ) s h o w e d
that the amphotericin B component of
these antibiotic disinfection mixtures
reduced cellular viability of porcine heart
valves by 100% after 12 h storage at 4℃.
The effect of antibiotics on cells and tis-
sues are dependent on the condition of
treatment, and the optimal time and tem-
perature of treatment are necessary to
maintain cellular viability and steriliza-
tion effect2 8 , 4 2 , 5 3 ). Therefore, reducing dam-
age of antibiotics to cells and tissues can
provide the basis to improve cellular via-
bility and function in the grafted tissue.
In our previous study, it was shown that
antibiotic treatment for 4 h at 4℃w a s
the optimal condition for antibacterial
activity with maintaining cellular viability
in canine veins4 3 , 4 4 ).
In recent years, researchers and sur-
geons have been investigating the use of
cryopreserved allograft veins for tissue
transplantation. The cryopreservation of
tissue at -70℃to -196℃offers the
prospect of indefinite storage. The preser-
vation method of an acquired tissue influ-
ences the viability of cells such as fibrob-
lasts and endothelial cells. The harvest-
ing, an interval between the arrest of
d o n o r’s heart and preservation of valves
in refrigeration, sterilization(antibiotic
treatment), cryopreservation, and thaw-
ing are primary factors which affect the
cellular physiology2 , 4 , 6 7 ). According to the
previous study, the viability of cells in
the harvested veins was gradually
reduced during cryopreservation and then
rapidly decreased after thawing(Fig.
1 )4 2 , 4 3 ). To overcome these problems, the
conventional combination of antibiotics
used at Toronto Tissue Bank(Table 4) was
cha ged into the new one. It has been
developed to improve cellular viability, to
maximize sterilizing power, and to trigger
synergistic effect and then employed at
Yonsei Cardiovascular Tissue Bank(Table
5 )4 5 ). Li c mycin was substituted with
clindamycin in order to extend limited
antimicr bial spectrum only for Gram-
posit ve bacteria. Moreover, cefoxitin was
entrapped with liposome to give the possi-
b lity to improve the cellular viability by
controlling the excess presentation of drug
in tissue. In terms of sterilization effect,
liposomal cefoxitin showed the antibacter-
ial effect comparable to the free cefoxitin,
indicating that liposomal entrapment of
cefoxitin could not affected the original
antibiotic effect.
In conclusion, when pretreated to
human saphenous vein, liposomal entrap-
ment of cefoxitin could improve the via-
bility and function of endothelial cells
and maintain the original sterilization
ffect. Th  antibiotics described here
would also be useful for sterilization of
other grafts for transplantation in which
c llular viability and function should be
considered important.
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